Edesa Biotech, Inc. - Common Stock (EDSA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2025

Type / Class
Equity / Common Stock
Symbol
EDSA on Nasdaq
Shares outstanding
7,005,566
Price per share
$1.44
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,876,709
Total reported value
$7,101,619
% of total 13F portfolios
0%
Share change
+768,591
Value change
+$1,897,089
Number of holders
23
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Edesa Biotech, Inc. - Common Stock (EDSA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nijhawan Pardeep 20% $3,767,931 1,596,581 Pardeep Nijhawan 12 Feb 2025
Nantahala Capital Management, LLC 10% $1,653,152 700,488 Nantahala Capital Management, LLC 31 Mar 2025
Stonepine Capital Management, LLC 9.9% $1,636,780 693,551 Stonepine Capital Management, LLC 13 Feb 2025
Velan Capital Investment Management LP 10% $1,636,780 693,551 Velan Capital Investment Management LP 12 Feb 2025

As of 30 Sep 2025, 23 institutional investors reported holding 2,876,709 shares of Edesa Biotech, Inc. - Common Stock (EDSA). This represents 41% of the company’s total 7,005,566 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Edesa Biotech, Inc. - Common Stock (EDSA) together control 41% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Stonepine Capital Management, LLC 9.8% 687,500 1.4% $1,698,125
Rubric Capital Management LP 9.8% 687,500 0% 0.02% $1,698,125
Velan Capital Investment Management LP 9.8% 687,500 0% 1.6% $1,698,125
Nantahala Capital Management, LLC 8.9% 625,000 0% 0.1% $1,543,750
VANGUARD GROUP INC 0.65% 45,543 +187% 0% $111,125
GEODE CAPITAL MANAGEMENT, LLC 0.65% 45,234 +62% 0% $110,382
COMMONWEALTH EQUITY SERVICES, LLC 0.54% 37,548 +7.3% 0% $93,000
RENAISSANCE TECHNOLOGIES LLC 0.36% 25,000 0% $61,750
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.21% 14,610 0% $35,648
CITADEL ADVISORS LLC 0.2% 14,032 -40% 0% $34,238
CITIGROUP INC 0.03% 2,000 0% $4,880
UBS Group AG 0.03% 1,819 +166% 0% $4,493
ROYAL BANK OF CANADA 0.03% 1,816 0% 0% $4,000
Tower Research Capital LLC (TRC) 0.02% 1,279 -45% 0% $3,159
TD Waterhouse Canada Inc. 0% 142 0% 0% $362
FIFTH THIRD BANCORP 0% 100 0% 0% $247
BANK OF AMERICA CORP /DE/ 0% 51 -5.6% 0% $126
Global Retirement Partners, LLC 0% 25 0% 0% $62
BARCLAYS PLC 0% 6 0% $14
DANSKE BANK A/S 0% 1 0% 0% $2
Dogwood Wealth Management LLC 0% 1 0% 0% $2
LRI Investments, LLC 0% 1 0% 0% $2
AllSquare Wealth Management LLC 0% 1 0% 0% $2
RAYMOND JAMES FINANCIAL INC 0% 0 -100% $0
CREDIT AGRICOLE S A 0% 0 -100% $0

Institutional Holders of Edesa Biotech, Inc. - Common Stock (EDSA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 2,876,709 $7,101,619 +$1,897,089 $2.47 23
2025 Q2 2,108,117 $4,279,068 -$1,739,763 $2.03 20
2025 Q1 2,822,207 $6,885,740 +$6,475,156 $2.44 19
2024 Q4 207,513 $350,110 +$46,292 $1.68 16
2024 Q3 161,348 $718,217 +$49,169 $4.45 17
2024 Q2 150,715 $645,126 +$183,339 $4.28 17
2024 Q1 107,880 $450,876 -$12,949 $4.19 17
2023 Q4 110,845 $507,117 +$507,117 $4.57 19